49 results
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
15 May 24
Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
9:01am
and future laws and regulations relating to fraud and abuse, false claims, transparency, health information privacy and security, and other healthcare
424B3
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement
4:53pm
of current and future laws and regulations relating to fraud and abuse, false claims, transparency, health information privacy and security, and other
424B5
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement for primary offering
4:52pm
regulatory scrutiny;
the effects of current and future laws and regulations relating to fraud and abuse, false claims, transparency, health
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
1 May 24
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
4:28pm
claims, transparency, health information privacy and security, and other healthcare laws and regulations; the effects of competition for our product
8-K
EX-99.1
pcmu5
26 Apr 24
Avenue Therapeutics Announces Reverse Stock Split
4:39pm
8-K
EX-99.1
luoteadsv
18 Mar 24
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
4:10pm
424B3
zifi4xn8665y hncnnv8
2 Feb 24
Prospectus supplement
12:00am
424B4
kzyxm9ogau9dm
2 Nov 23
Prospectus supplement with pricing info
9:00am
FWP
0wza7j1 jdkway
5 Oct 23
Free writing prospectus
5:05pm
FWP
hxtp3r
3 Oct 23
Free writing prospectus
5:47pm
424B3
zjj5kc 7j8g
28 Jun 23
Prospectus supplement
4:56pm